重组牛碱性成纤维细胞生长因子滴眼液和新泪然联用治疗干眼症并角膜上皮损伤疗效分析.docVIP

重组牛碱性成纤维细胞生长因子滴眼液和新泪然联用治疗干眼症并角膜上皮损伤疗效分析 　　[摘要] 目的 分析重组牛碱性成纤维细胞生长因子（rhEGF）滴眼液与新泪然联用治疗干眼症并角膜上皮损伤疗效。方法 方便选取该院2016年5―10月间收治的干眼症并角膜上皮损伤患者50例。将其简单随机分为两组，25例为一组。对照组干眼症并角膜上皮损伤患者单一使用新泪然治疗，观察组干眼症并角膜上皮损伤患者给予rhEGF滴眼液与新泪然联用治疗。对比两组患者治疗前后的泪膜破裂时间、角膜荧光染色评分、结膜充血症状评分以及不良反应的发生概率。 结果 观察组干眼症并角膜上皮损伤患者治疗前后的泪膜破裂时间、角膜荧光染色评分以及结膜充血症状评分均优于对照组，差异有统计学意义（P0.05），且不良反应的发生概率（8.00%）低于对照组（24.00%），差异有统计学意义（P0.05）。结论 rhEGF滴眼液与新泪然联用治疗干眼症并角膜上皮损伤患者的效果较为可观。 　　[关键词] 新泪然；干眼症并角膜上皮损伤；rhEGF滴眼液；疗效分析 　　[中图分类号] R777 [文献标识码] A [文章编号] 1674-0742（2017）01（a）-0139-03 　　Recombinant Bovine Basic Fibroblast Growth Factor（rhEGF）and New Tears Ran Combined with in Treatment of Dry Eye and Corneal Epithelial Damage Curative Effect Analysis 　　LI Mi， DAI Zhui， YANG Wen-yan 　　The Department of Ophthalmology of Qidong Peoples Hospital， Qidong， Jiangsu Province， 226200 China 　　[Abstract] Objective Analysis of recombinant bovine basic fibroblast growth factor （rhEGF） tears eye drops and then combined with the new treatment of dry eye and corneal epithelial damage effect. Methods Convenient selection our hospital， dry eye and corneal epithelial injury in 50 patients （May 2016 to October 2016）. Its simple randomized divided into two groups， 25 cases as a group. The control group of patients with dry eye and corneal epithelial damage single tear ran with the new treatment， the observation group dry eye and corneal epithelial damage in patients given eye drops and new tears ran rhEGF combination therapy. Compare the probability of tear breakup time before and after the group 2 patients， corneal fluorescein staining scores， conjunctival congestion symptom scores and adverse reactions. Results The dry eye and corneal epithelial injury patients before and after treatment of the tear film breakup time， corneal fluorescein staining score and conjunctival congestion symptom scores than the control group （P 0.05）， and the probability of occurrence of adverse events （8.00% ） than the control group （24.00%）， （P 0.05）. Conclusion rhEGF tear